New patterns of HIV-1 resistance during HAART-Reference-Cited by-同舟云学术

New patterns of HIV-1 resistance during HAART

Published:2003-11 Issue:11 Volume:9 Page:1077-1084
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Fumero E.,Podzamczer D.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference59 articles.

1. Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the VIRA-DAPT study;Durant;AIDS,2000

2. Individualising HIV treatment—pharmacogenetics and immunogenetics;Telenti;Lancet,2002

3. In vivo emergence of drug-resistant mutations at less than 50 HIV-1RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from HIV-1 infected patients on HAART;Elbeik;J Hum Virol,2001

4. Drug-resistance genotyping in HIV-1 therapy: the VIR-ADAPT randomised controlled trial;Durant;Lancet,1999

5. A randomised study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy;Baxter;AIDS,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors In Vitro;Antimicrobial Agents and Chemotherapy;2022-02-15

2. Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs;Molecules;2019-09-06

3. Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications;Antimicrobial Agents and Chemotherapy;2019-07

4. Modeling the full length HIV-1 Gag polyprotein reveals the role of its p6 subunit in viral maturation and the effect of non-cleavage site mutations in protease drug resistance;Journal of Biomolecular Structure and Dynamics;2017-12-27

5. GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro;Scientific Reports;2017-09-25